WHO ICTRP trial
Bioequivalence study of crushed Triumeq with or without drip feed compared to…
NL-OMON42415 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON42415 |
|---|---|
| Public title | Bioequivalence study of crushed Triumeq with or without drip feed compared to the whole tablet. |
| Scientific title | Bioequivalence study of crushed Triumeq with or without drip feed compared to the whole tablet. - SCRUM |
| Primary sponsor | Afdeling Apotheek |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | HIV;10047438 |
| Interventions | See study design. 3 different ways of administration of Triumeq: - whole tablet - crushed and suspended tablet - standard amount of drip feed followed by a crushed and suspended tablet ;Bioequivalence;Crushed;Drip feed;Triumeq |
| Registration date | Oct 15, 2015 |
| Target size | 24 |
| Secondary IDs | 2015-002280-42;NL54232.091.15 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: